Frazier Life Sciences: Fairey holds 30,000 shares
Conversion is automatic around the initial business combination or may occur earlier at the director’s option, subject to adjustment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Frazier Life Sciences Acquisition Corp. II (FLSC) reports that director William Fairey directly holds 30,000 Class B ordinary shares as of October 13, 2026. The shares automatically convert into Class A ordinary shares on a one-for-one basis, subject to adjustment, immediately prior to, concurrently with or immediately following the consummation of the issuer’s initial business combination. William Fairey may also elect conversion at any time before then. The shares have no expiration date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Class B ordinary shares F1 | -- | -- | -- |
Footnotes (1)
- F1. The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares immediately prior to, concurrently with or immediately following the consummation of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date.
Key Figures
Key Terms
one-for-one basis technical
initial business combination financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.